Loading...
Nikon Community
TSE:7731 Community- 1 Narratives written by author
- 0 Comments on narratives written by author
- 1 Fair Values set on narratives written by author
Community Investing Ideas
Acquisition Of RED And Growth In Cell Therapy Propel Revenue And Margins In Imaging And Healthcare
Key Takeaways Nikon's acquisition of RED enhances its video strategy, potentially boosting revenue in the Imaging Products Business. Nikon's pivot in the CDMO business, focusing on cell therapy, may solidify new revenue streams in the Healthcare sector.Read more
0users have liked this narrative
0users have commented on this narrative
1users have followed this narrative
AN
JP¥1.51k
19.2% overvalued intrinsic discount
AnalystConsensusTarget Fair Value
Revenue growth
1.96% p.a.
Profit Margin
5.64%
Future PE
12.4x
Share price in 2028
JP¥1.87k